Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes

Heather C. Mefford(University of Washington), Andrew J. Sharp(University of Geneva), Carl Baker(University of Washington), Andy Itsara(University of Washington), Zhaoshi Jiang(University of Washington), Karen Buysse(Ghent University Hospital), Shuwen Huang(Salisbury NHS Foundation Trust), Viv Maloney(Wessex Regional Genetics Laboratory), John A. Crolla(Salisbury NHS Foundation Trust), Diana Baralle, Amanda Collins(University of Naples Federico II), Catherine Mercer, Koen Norga(Vlaams Instituut voor Biotechnologie), Thomy de Ravel(KU Leuven), Koenraad Devriendt(KU Leuven), Ernie M.H.F. Bongers(Radboud University Nijmegen), Nicole de Leeuw(Radboud University Nijmegen), William Reardon(Our Lady's Hospital), Stefania Gimelli(Geneva College), Frédérique Béna(Geneva College), Raoul C. M. Hennekam(University College London), Alison Male(Great Ormond Street Hospital), Lorraine Gaunt(St. Mary’s Hospital), Jill Clayton‐Smith(St. Mary’s Hospital), Ingrid Simonic(Addenbrooke's Hospital), Soo Mi Park(Addenbrooke's Hospital), Sarju Mehta(Addenbrooke's Hospital), Serena Nik‐Zainal(Addenbrooke's Hospital), C. Geoffrey Woods(Addenbrooke's Hospital), Helen V. Firth(Addenbrooke's Hospital), Georgina Parkin(Addenbrooke's Hospital), Marco Fichera(Oasi Maria SS), S Reitano(Oasi Maria SS), Mariangela Lo Giudice(Oasi Maria SS), Kelly E. Li, Iris Casuga, Adam Broomer, Bernard Conrad(University Children’s Hospital Bern), Markus Schwerzmann(University Hospital of Bern), Lorenz Räber(University Hospital of Bern), Sabina Gallati(University Children’s Hospital Bern), Pasquale Striano(Istituto Giannina Gaslini), Antonietta Coppola(University of Naples Federico II), John Tolmie(Royal Hospital for Children), Edward S. Tobias(Royal Hospital for Children), Chris J. Lilley(Royal Hospital for Children), Lluı́s Armengol(Pompeu Fabra University), Yves Spysschaert(Ghent University Hospital), Patrick Verloo(Ghent University Hospital), Anja De Coene(University of Naples Federico II), Linde Goossens(Ghent University Hospital), Geert Mortier(Ghent University Hospital), Frank Speleman(Ghent University Hospital), Ellen van Binsbergen(University Medical Center Utrecht), Marcel Nelen(University Medical Center Utrecht), Ron Hochstenbach(University Medical Center Utrecht), Martin Poot(University Medical Center Utrecht), Louise Gallagher(St. James's Hospital), Michael Gill(St. James's Hospital), Jon McClellan(University of Washington), Mary‐Claire King(University of Washington), Regina Regan(Centre for Human Genetics), Cindy Skinner(Greenwood Genetic Center), Roger E. Stevenson(Greenwood Genetic Center), Stylianos E. Antonarakis(University of Geneva), Caifu Chen, Xavier Estivill(Pompeu Fabra University), Björn Menten(Ghent University Hospital), Giorgio Gimelli(Istituto Giannina Gaslini), Susan Gribble(Wellcome Sanger Institute), Stuart Schwartz(University of Chicago), James S. Sutcliffe(Vanderbilt University), Tom Walsh(University of Washington), Samantha J.L. Knight(Centre for Human Genetics), Jonathan Sebat(Cold Spring Harbor Laboratory), Corrado Romano(Oasi Maria SS), Charles E. Schwartz(Greenwood Genetic Center), Joris A. Veltman(Radboud University Nijmegen), Bert B.A. de Vries(Radboud University Nijmegen), Joris Vermeesch(KU Leuven), John Barber(Salisbury NHS Foundation Trust), Lionel Willatt(Addenbrooke's Hospital), May Tassabehji(University of Manchester), Evan E. Eichler(Howard Hughes Medical Institute)
New England Journal of Medicine
September 10, 2008
Cited by 810Open Access
Full Text

Abstract

BACKGROUND: Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of submicroscopic imbalances in large numbers of patients. METHODS: We tested for the presence of microdeletions and microduplications at a specific region of chromosome 1q21.1 in two groups of patients with unexplained mental retardation, autism, or congenital anomalies and in unaffected persons. RESULTS: We identified 25 persons with a recurrent 1.35-Mb deletion within 1q21.1 from screening 5218 patients. The microdeletions had arisen de novo in eight patients, were inherited from a mildly affected parent in three patients, were inherited from an apparently unaffected parent in six patients, and were of unknown inheritance in eight patients. The deletion was absent in a series of 4737 control persons (P=1.1x10(-7)). We found considerable variability in the level of phenotypic expression of the microdeletion; phenotypes included mild-to-moderate mental retardation, microcephaly, cardiac abnormalities, and cataracts. The reciprocal duplication was enriched in nine children with mental retardation or autism spectrum disorder and other variable features (P=0.02). We identified three deletions and three duplications of the 1q21.1 region in an independent sample of 788 patients with mental retardation and congenital anomalies. CONCLUSIONS: We have identified recurrent molecular lesions that elude syndromic classification and whose disease manifestations must be considered in a broader context of development as opposed to being assigned to a specific disease. Clinical diagnosis in patients with these lesions may be most readily achieved on the basis of genotype rather than phenotype.


Related Papers

No related papers found

Powered by citation graph analysis